Bionema Group launches tender for cutting-edge plant health solutions
Added on 01 July 2024
In response to growing public concern over the impact of synthetic fertilisers on soil health and the environment, Bionema is committed to providing comprehensive, eco-friendly alternatives. Bionema's extensive collection of researched biostimulants and biofertilisers offers practical solutions tailored for greenkeepers, racecourse managers, groundsmen, farmers, and foresters. This initiative builds on Bionema's product and technology acquisition by Syngenta in 2021, reinforcing our position as a global leader in plant health management, and introduces products based on advanced Biofilm technology.
Bionema has been at the forefront of developing sustainable agricultural products at Swansea University, Wales, headquarters for decades. Our growth aligns with evolving market demands, particularly in light of the EU's commitment to reducing synthetic fertiliser use by 20% by 2030.
Our diverse range of products includes biostimulants such as PGPR, nutrients, prebiotics & vitamins, triacontanol, acetyl thiazolidine carboxylic acid, and calcium peroxide.
Our biofertilisers feature nitrogen-fixing bacteria, phosphorus-solubilizing bacteria, silica-solubilizing bacteria, potash-mobilizing bacteria, sulphur-mobilizing bacteria, iron-mobilizing bacteria, zinc-mobilizing bacteria, and manganese-mobilizing bacteria, all meticulously formulated to meet the needs of our customers.
Dr Minshad Ansari, Founder and CEO of Bionema Group, shared the company's visionary outlook: "Our goal is to lead the way in Biological Agriculture technology, reducing reliance on synthetic pesticides and fertilisers. Sustainable alternatives are essential with global trends shifting and increasing demands from consumers, society, and regulators. The EU's ambitious plan to ban 50% of pesticides by 2030 and significantly expand organic farming necessitates innovative solutions like ours. The EU aims to reduce fertiliser use by at least 20% by 2030 as part of its Farm to Fork Strategy, focusing on decreasing nutrient losses by 50% without compromising soil fertility and increasing organic farming land by up to 25%."
Bionema's expanded portfolio strengthens our presence in the Biological Agriculture sector, enhancing our ongoing research and development, farmer training, and additional services to advance biological solutions across various cropping systems. Our innovative microencapsulated formulation and delivery platform technology enables the creation of products with 20-30% higher efficacy and productivity than existing alternatives.
Dr Ansari emphasised, "While we are excited to introduce our new products, our unwavering commitment to innovation and collaboration continues. We have achieved significant milestones, but our journey of progress is far from over. We are confident that the best is yet to come."
For more information about the tender and how to participate, please visit our website at www.bionema.com.
To discover more about Bionema Group and our innovative plant health management solutions, please visit www.bionema.com.
More news